Matches in Wikidata for { <http://www.wikidata.org/entity/Q53675802> ?p ?o ?g. }
- Q53675802 description "2014 nî lūn-bûn" @default.
- Q53675802 description "2014年の論文" @default.
- Q53675802 description "2014年学术文章" @default.
- Q53675802 description "2014年学术文章" @default.
- Q53675802 description "2014年学术文章" @default.
- Q53675802 description "2014年学术文章" @default.
- Q53675802 description "2014年学术文章" @default.
- Q53675802 description "2014年学术文章" @default.
- Q53675802 description "2014年學術文章" @default.
- Q53675802 description "2014年學術文章" @default.
- Q53675802 description "2014年學術文章" @default.
- Q53675802 description "2014年學術文章" @default.
- Q53675802 description "2014年學術文章" @default.
- Q53675802 description "2014년 논문" @default.
- Q53675802 description "article científic" @default.
- Q53675802 description "article scientific" @default.
- Q53675802 description "article scientifique" @default.
- Q53675802 description "articol științific" @default.
- Q53675802 description "articolo scientifico" @default.
- Q53675802 description "artigo científico" @default.
- Q53675802 description "artigo científico" @default.
- Q53675802 description "artigo científico" @default.
- Q53675802 description "artikel ilmiah" @default.
- Q53675802 description "artikull shkencor" @default.
- Q53675802 description "artikulong pang-agham" @default.
- Q53675802 description "artykuł naukowy" @default.
- Q53675802 description "artículo científico publicado en 2014" @default.
- Q53675802 description "artículu científicu" @default.
- Q53675802 description "bilimsel makale" @default.
- Q53675802 description "bài báo khoa học" @default.
- Q53675802 description "naučni članak" @default.
- Q53675802 description "scienca artikolo" @default.
- Q53675802 description "scientific article published on 15 October 2014" @default.
- Q53675802 description "scientific article published on 15 October 2014" @default.
- Q53675802 description "scientific article published on 15 October 2014" @default.
- Q53675802 description "teaduslik artikkel" @default.
- Q53675802 description "tieteellinen artikkeli" @default.
- Q53675802 description "tudományos cikk" @default.
- Q53675802 description "vedecký článok" @default.
- Q53675802 description "vetenskaplig artikel" @default.
- Q53675802 description "videnskabelig artikel" @default.
- Q53675802 description "vitenskapelig artikkel" @default.
- Q53675802 description "vitskapeleg artikkel" @default.
- Q53675802 description "vědecký článek" @default.
- Q53675802 description "wetenschappelijk artikel" @default.
- Q53675802 description "wissenschaftlicher Artikel" @default.
- Q53675802 description "επιστημονικό άρθρο" @default.
- Q53675802 description "мақолаи илмӣ" @default.
- Q53675802 description "наукова стаття, опублікована в жовтні 2014" @default.
- Q53675802 description "научна статия" @default.
- Q53675802 description "научная статья" @default.
- Q53675802 description "научни чланак" @default.
- Q53675802 description "научни чланак" @default.
- Q53675802 description "מאמר מדעי" @default.
- Q53675802 description "مقالة علمية نشرت في 15 أكتوبر 2014" @default.
- Q53675802 description "১৫ অক্টোবর ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q53675802 description "บทความทางวิทยาศาสตร์" @default.
- Q53675802 description "სამეცნიერო სტატია" @default.
- Q53675802 name "An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer." @default.
- Q53675802 name "An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer." @default.
- Q53675802 type Item @default.
- Q53675802 label "An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer." @default.
- Q53675802 label "An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer." @default.
- Q53675802 prefLabel "An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer." @default.
- Q53675802 prefLabel "An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer." @default.
- Q53675802 P1433 Q53675802-35A8C2A3-273E-469B-B968-132B41E31A10 @default.
- Q53675802 P1476 Q53675802-8B0DAC3A-6348-43CF-A395-1035115F3D1B @default.
- Q53675802 P2093 Q53675802-0D2CE00B-7814-4423-9C14-0CB0F71BE201 @default.
- Q53675802 P2093 Q53675802-5C7D3556-C0E3-4104-B84E-3A6146B52C03 @default.
- Q53675802 P2093 Q53675802-7B4E0C81-73E7-443C-8F6F-53B4CB95A6A5 @default.
- Q53675802 P2093 Q53675802-7C90581D-DAF7-4635-90D6-98D0CDB0BD45 @default.
- Q53675802 P2093 Q53675802-80C2C4E8-4061-4B43-96DF-A68740CEF61E @default.
- Q53675802 P2093 Q53675802-B1E314BF-44A1-4C81-8F7C-1D559991B31C @default.
- Q53675802 P2093 Q53675802-D3F166A7-53FD-487E-A980-C12071B66D0E @default.
- Q53675802 P2093 Q53675802-E5F6C1E2-A9F5-4E18-925C-9259A16598C1 @default.
- Q53675802 P304 Q53675802-F16DCC05-154D-43A4-A3A5-25CE8B82DAA7 @default.
- Q53675802 P31 Q53675802-0667FF2A-A6C8-4829-9602-2D2A79741412 @default.
- Q53675802 P356 Q53675802-E0B0C950-1BB1-40D6-8C4D-40B19288616D @default.
- Q53675802 P407 Q53675802-A36DC557-9FAC-4C36-8736-2900EF89F719 @default.
- Q53675802 P433 Q53675802-1761298B-2DBB-4682-9A28-90160588265C @default.
- Q53675802 P478 Q53675802-5E77244B-9557-497C-ABCC-74E820947006 @default.
- Q53675802 P50 Q53675802-59AA8EFD-2213-4490-A7E5-F3C605697440 @default.
- Q53675802 P50 Q53675802-CA9871EB-1F6B-4249-977C-388E0BFB7AD9 @default.
- Q53675802 P577 Q53675802-94CEB2B8-D4D9-44A4-A2CA-48352127E549 @default.
- Q53675802 P698 Q53675802-0EAC9A05-642A-48A1-AAEC-ACF025129F25 @default.
- Q53675802 P356 J.CLLC.2014.10.001 @default.
- Q53675802 P698 25458558 @default.
- Q53675802 P1433 Q332299 @default.
- Q53675802 P1476 "An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer." @default.
- Q53675802 P2093 "Anne Freeman" @default.
- Q53675802 P2093 "Brian Huber" @default.
- Q53675802 P2093 "Cornelius F Waller" @default.
- Q53675802 P2093 "Harish Dave" @default.
- Q53675802 P2093 "Jeffrey P Hodge" @default.
- Q53675802 P2093 "Mark J Shelton" @default.
- Q53675802 P2093 "Ronald Lieberman" @default.
- Q53675802 P2093 "Yaroslav Shparyk" @default.
- Q53675802 P304 "92-99" @default.
- Q53675802 P31 Q13442814 @default.
- Q53675802 P356 "10.1016/J.CLLC.2014.10.001" @default.